Causaly
This innovative drug discovery software leverages a high-precision biomedical knowledge graph and advanced AI to enhance R&D productivity by up to 90%. Scientists can swiftly navigate complex biological relationships, identify safety red flags, and unlock actionable insights from millions of data sources, revolutionizing their research processes and accelerating the development of life-changing therapies.
Top Causaly Alternatives
StackScan
Curious about a website’s technology stack? Use StackScan to explore 50,000+ technologies across 450+ categories of stacks.
StarDrop
StarDrop™ is an advanced drug discovery software that streamlines the transition from data analysis to decision-making. It enhances the research process by visualizing structure-activity relationships and optimizing compound properties. With its unique predictive modeling capabilities and AI integration, StarDrop™ empowers researchers to efficiently identify and design compounds with optimal activity and safety profiles.
LigPlot+
LigPlot+ is an advanced tool for automatically creating 2D ligand-protein interaction diagrams, featuring an intuitive Java interface that supports on-screen editing through click-and-drag functionality. Enhancements include automatic superposition of similar complexes, highlighting conserved interactions, and an updated DIMPLOT for visualizing protein-protein or domain-domain interactions efficiently.
Cerella
Cerella revolutionizes drug discovery by harnessing data to uncover hidden insights and optimize compound selection. Utilizing advanced machine learning, it accurately predicts missing values, allowing researchers to maximize resources despite limited datasets. This AI-driven tool enhances decision-making, streamlining workflows to accelerate the identification of promising drug candidates and improve project outcomes.
AlphaFold
AlphaFold revolutionizes biological research by predicting protein structures with remarkable accuracy. Since its inception in 2020, it has unveiled over 200 million intricate 3D configurations, drastically reducing the time and cost associated with protein analysis. This innovation empowers scientists across various fields, accelerating discoveries that address critical medical and environmental challenges.
Healnet
Healnet revolutionizes drug discovery by leveraging AI to analyze extensive drug and disease data, uncovering novel treatment connections for rare diseases. It integrates biomedical literature, curated biological data, and biochemical insights, enabling parallel processing of multiple discovery stages, thus challenging traditional one-target models and enhancing the potential for impactful therapies.
Eidogen-Sertanty Target Informatics Platform (TIP)
The Target Informatics Platform (TIP) revolutionizes structural informatics by allowing researchers to explore the druggable genome through a structural lens. It enhances the utilization of experimental protein structure data, shifting structure-based drug discovery into a high-throughput, data-rich domain, while effectively merging bioinformatics and cheminformatics insights to optimize the discovery pipeline.
Mass Dynamics
Unlocking the potential of mass spectrometry and proteomics, this solution streamlines biological biomarker discovery and drug development. Its automated workflow enhances experiment efficiency, enabling rapid insights into disease mechanisms and protein level changes. By leveraging cloud processing, it supports scalability and facilitates collaboration, allowing researchers to concentrate on impactful biological findings.
SpliceCore
SpliceCore leverages RNA sequencing data and advanced artificial intelligence to transform therapeutic development for splicing errors. With a unique database of over 5 million splicing errors, it rapidly identifies and validates potential drug targets. Scalable cloud computing enhances processing speed and efficiency, propelling innovative RNA therapeutics discovery forward.
VeraChem
VeraChem offers advanced computational chemistry software designed for precision in drug discovery. It features robust tools for predicting protein-ligand binding affinities, calculating accurate partial atomic charges, and employing the Tork algorithm for conformational searches. Additionally, it automates resonance form generation and detects molecular symmetries, enhancing research efficiency.
SILCS
SILCS is a cutting-edge drug discovery software that employs Site Identification by Ligand Competitive Saturation to produce 3D FragMaps, revealing interaction patterns of functional groups with target molecules. This platform enhances ligand optimization through dynamic insights into binding pockets, facilitating efficient drug design and rapid exploration of favorable interactions.
DrugPatentWatch
Recognized by reputable sources like CNN and NEJM, DrugPatentWatch empowers users with continuously updated drug patent data directly from primary sources. Subscribers benefit from flexible plans, AI-driven insights, and essential alerts, enabling them to anticipate patent expirations, identify generic suppliers, and make informed strategic decisions in biopharmaceuticals.
Basesoft PharmaSuite
PharmaSuite elevates the safety and efficiency of hospital pharmacy services with its advanced software solution. It ensures complete traceability from raw materials to finished products, integrates seamlessly with existing hospital systems, and minimizes human error. The platform also offers tailored training and reliable technical support, enhancing operational quality and patient care.
SYNTHIA Retrosynthesis Software
SYNTHIA Retrosynthesis Software revolutionizes drug discovery by allowing scientists to identify innovative synthetic pathways for both new and existing target molecules. Leveraging over 12 million starting materials, it offers real-time analysis, customizable search parameters, and efficient pathway visualization, enhancing the synthesis planning process while supporting green chemistry initiatives.
Aurora Drug Discovery
Leveraging advanced quantum mechanics and thermodynamics, Aurora Drug Discovery utilizes an innovative continuous water model to calculate ligand binding affinities. By incorporating entropy and electrostatic contributions directly into its algorithms, Aurora generates precise binding free energy values, enhancing the prediction of inhibition constants and improving drug discovery outcomes significantly.
AutoDock
AutoDock is an advanced suite of automated docking tools designed to accurately predict the binding interactions of small molecules, such as drug candidates, with receptors of known 3D structures. It features multiple docking engines, including the groundbreaking AutoDock-GPU, which offers accelerated performance and enhanced functionalities for protein-ligand interactions.
Company Information
- Company: Causaly
- Country: United Kingdom
Top Causaly Features
- High-precision biomedical knowledge graph
- AI copilot for scientists
- Rapid target identification
- Streamlined biomarker research
- Comprehensive causal biology topics
- Inline hyperlinked citations
- Central AI governance mechanism
- Modular GenAI Operating System
- Secure enterprise data fabric
- External and internal data integration
- Real-time data updates
- Rigorous data analysis capabilities
- User-friendly search functionality
- Extensive indexing and extraction
- Proven productivity enhancement
- Digital transformation support services
- Customizable AI architecture
- Collaborative research environment
- Evidence consolidation from publications
- High-speed information retrieval
